A sorption-based, adhesive contact apparatus and method for contact cooling a patient via conductive thermal exchange are described. The apparatus includes a pad, having a fluid containing layer and adhesive contact surface, and a sorption-based device, fluidly interconnectable to the fluid containing layer, for vaporizing fluid contained in the fluid containing layer and for sorping the vaporized fluid. The fluid vaporization and the vapor sorption cools the adhesive contact surface of the pad. A port control member may selectively establish fluid interconnection between the fluid containing layer and sorption-based device. An internal pressure of the sorption-based device may be established lower than an internal pressure of the fluid-containing layer prior to fluid interconnection therebetween. A fluid retention member and path defining members may be included to facilitate vaporization, vapor diffusion and vapor sorption, thereby enhancing uniform cooling.
|
1. A method for providing a cooled surface for contact cooling of a patient, comprising:
vaporizing fluid contained in a fluid containing layer of a patient contact pad having an adhesive surface disposed on one side thereof for contacting a patient to provide conductive cooling, wherein said fluid containing layer includes an enclosure that restricts the passage of vapor therethrough and a fluid retention member located within the enclosure for retaining the fluid; and,
sorping the vaporized fluid within a sorption-based device;
wherein said adhesive surface of said patient contact pad is cooled.
2. A method as recited in
3. A method as recited in
4. A method as recited in
5. A method as recited in
6. A method as recited in
providing said sorption-based device at an internal pressure less than an internal pressure of the fluid containing layer of said patient contact pad prior to selective establishment of a fluid interconnection therebetween.
7. A method as recited in
providing said sorption-based device at a predetermined sub-atmospheric pressure.
8. A method as recited in
vaporizing fluid contained in the fluid retention member located within the enclosure of the fluid containing layer across the lateral extent of the fluid retention member.
9. A method as recited in
diffusing the vaporized fluid across the lateral extent of the fluid retention member to at least one open port disposed between the fluid containing layer of the patient contact pad and the sorption-based device.
10. A method as recited in
passing the vaporized fluid through each of a plurality of vapor diffusion paths defined between the fluid retention member and the at least one open port.
11. A method as recited in
extracting thermal energy released in conjunction with said sorping in said sorption-based device.
12. A method as recited in
utilizing a phase-change material disposed in said sorption-based device to extract said thermal energy.
13. A method as recited in
providing said patient contact pad and said sorption-based device together from a first location to a second location prior to use in said vaporizing and said sorping at said second location.
14. A method as recited in
packaging said patient contact pad and said sorption-based device together at said first location.
15. A method as recited in
16. A method as recited in
a first material suspended in a matrix defined by a second material, wherein said first material comprises a liquid and said second material comprises a polymer.
17. A method as recited in
a porous material, wherein retention of said fluid is distributed across a lateral extent of said fluid retention member.
18. A method as recited in
|
|||||||||||||||||||||||||||||
This application is a continuation of U.S. patent application Ser. No. 12/101,610, filed Apr. 11, 2008, entitled “SORPTION-BASED ADHESIVE CONTACT COOLING APPARATUS AND METHOD, which claims priority to U.S. Patent Provisional Application Ser. No. 60/911,464, filed Apr. 12, 2007, entitled “SORPTION-BASED ADHESIVE CONTACT COOLING APPARATUS AND METHOD”, the entirety of which is hereby incorporated by reference.
The present invention generally relates to a sorption-based, adhesive contact-cooling apparatus and method for cooling a patient. The invention is particularly apt for treating stroke, head trauma and cardiac arrest patients in an ambulatory vehicle or other emergency treatment site.
The therapeutic use of rapid bodily cooling systems is ever-increasing. Of particular interest, it is now accepted that rapid cooling of stroke, cardiac arrest and head trauma patients can yield significant therapeutic benefits. Specifically, research indicates that even though a stroke or cardiac arrest victim's brain cells may loose their ability to function, the cells do not necessarily die quickly. In fact, brain damage from a stroke or cardiac arrest may take hours to reach maximum effect. Neurological damage may be reduced and the stroke or cardiac arrest victims' outcome improved if a neuroprotectant therapy is applied within this time frame.
Similarly, elements in the genesis of a traumatic brain injury (e.g., resulting from falls, vehicular accidents and the like) are now understood to overlap with elements in the genesis of neurological damage in stroke victims. In particular, delayed secondary injury at the cellular level after the initial head trauma is now recognized as a major contributing factor to the ultimate tissue loss that occurs after brain injury. Again, neurologic damage may be reduced if a neuroprotectant therapy is rapidly applied. Further, in this regard, studies have shown that treatment with mild hypothermia, defined as lowering core body temperature at 2-3C° confers neuroprotection in stroke victims, and may hasten the neurologic recovery and improve outcomes when applied for 12-72 hours in cases of traumatic head injury. Again, to optimize such therapies, the neuro-protective therapy should be initiated as soon as possible after a stroke or traumatic head injury.
As these and other medical applications for rapid bodily cooling have continued to evolve, the present inventors have recognized the desirability of enhancing the portability, stowability and ease-of-use of patient cooling systems so that patient treatment may be promptly initiated. More particularly, while known patient cooling systems have proven effective for many applications, the present inventors have recognized that additional emergency-oriented applications can be realized via the implementation of further improved liquid cooling methodologies and stand-alone componentry, as well as enhanced componentry packaging. In this regard, the present inventors have recognized the need for a cooling system and related methodology that is particularly apt for use in ambulatory settings, including, in particular, use in emergency vehicles such as helicopters, ambulances and the like where space utilization is at a premium and patient access may be limited.
In view of the foregoing, a primary objective of the present invention is to provide a portable patient cooling apparatus and related method that reduces space storage and emergency treatment site space requirements, is light weight and yields highly effective patient cooling.
A further objective of the present invention is to provide an apparatus and method for patient cooling that is easy to set-up and is otherwise user-friendly.
Another objective of the present invention is to provide an on-demand patient cooling apparatus and method that reduces or avoids the need for electrical or other emergency treatment site power utilities.
Another objective of the present invention is to provide an improved patient cooling apparatus and method that is cost effective.
Yet another objective of the present invention is to provide an apparatus and method for patient cooling that is adapted for single patient use and ready disposal.
These and other objectives and advantages are achieved by one or more aspects of the present invention. According to one aspect of the present invention, an inventive apparatus is provided that includes a pad for contacting and thereby absorbing heat from a patient. The pad comprises a fluid containing layer and an adhesive contact surface disposed on one side of the fluid containing layer for intimately contacting a patient to yield conductive cooling. The inventive apparatus further includes a sorption-based device, fluidly interconnectable to the fluid containing layer of the pad, for selectively vaporizing fluid contained in the fluid containing layer of the pad and for sorping the vaporized fluid to yield a cooling effect at the adhesive contact surface.
As will be appreciated, the combinative employment of a sorption-based device and adhesive contact cooling surface not only yields rapid, conductive patient cooling across the contact surface of the pad, but also facilitates the realization of numerous additional benefits, including enhanced portability, stowability and efficient, on-demand cooling. Further, the combinative employment of a sorption-based device and adhesive contact pad avoids the need for electrical or other power requirements for patient cooling.
The sorption-based device may be provided with an internal pressure that is less than an internal pressure of the fluid containing layer of the pad, e.g., prior to use. In one approach, an enclosed volume of the sorption-based device may be maintained at a predetermined subatmospheric pressure, e.g., a predetermined subatmospheric pressure less than about 5 hectopascals (hPa). By virtue of the internal pressure differential between the sorption-based device and fluid containing layer of the pad, vaporization of fluid within the fluid containing layer may be facilitated upon the establishment of a fluid interconnection between the fluid containing layer and sorption-based device.
The apparatus may include at least one port control member for selectively controlling at least one port that fluidly interconnects the fluid containing layer and sorption-based device. In one approach, a port control member may be manually moveable from a first position in which the port is closed to another position in which the port is open. In this regard, the port control member may be completely removable from or interconnected/moveable relative to the apparatus. Further the port control member may be provided to allow for selective control over the size of a fluid interconnection opening defined by the port, wherein user control over a rate of cooling may be realized.
In one embodiment, the port may be biased to automatically open when the port control member is moved from the first position. By way of example, a port comprising a flexible material and an interconnected, interfacing spring member may be utilized, wherein the spring member is of a loop-type configuration and is biased to automatically expand from a closed-loop to an open-loop configuration when an external port control member is moved relative thereto, e.g., disengaged therefrom.
In one embodiment, the fluid containing layer of the apparatus may be of a pliable or flexible construction on at least said adhesive contact side thereof, thereby facilitating conformal and intimate contact interface with a patient. Further, the fluid containing layer may include an enclosure and a fluid retention member, located within the enclosure adjacent to the contact side of the pad, for retaining fluid. In the latter regard, the fluid retention member may include an open porous material, wherein the retention of fluid is distributed across a lateral extent of the fluid retention member. For example, it may be preferable for the fluid to be retained in a relatively uniform amount per unit volume across the lateral extent of the fluid retention member, thereby facilitating more uniform fluid vaporization and thermal exchange across the lateral extent of the pad of the inventive apparatus. In one embodiment, the fluid retention member may comprise a woven or non-woven material (e.g., a fabric material).
As noted, the apparatus may include at least one port disposed between the fluid containing layer of the pad and the sorption-based device. In turn, in one embodiment, the fluid containing layer may further include a first path defining means, located within an enclosure adjacent to a fluid retention member, for defining a first plurality of vaporized fluid diffusion paths between the fluid retention member and the at least one port. As may be appreciated, the first path defining means facilitates diffusion of vaporized fluid across the lateral extent of the fluid containing layer. In this regard, the first plurality of vaporized fluid diffusion paths may have corresponding end locations that are distributed across the lateral extent of the fluid retention member (e.g., spaced lengthwise and widthwise across the pad), thereby facilitating more uniform diffusion of vaporized fluid and corresponding thermal exchange.
In one embodiment, a first plurality of vaporized diffusion paths may include fluidly interconnected, tortuous paths. In this regard, the first plurality of vaporized fluid diffusion paths may each pass through at least two layers. For example, the first path defining means may be defined by a first plurality of elongated members arranged in the first layer and oriented in a first direction, and a second plurality of elongated members arranged in the second layer and orientated in a second direction transverse to said first direction (e.g., to define a cross-hatch pattern). The first plurality of elongated members may be arranged within the first layer in a parallel fashion and the second plurality of elongated members may be arranged in the second layer in a parallel fashion. In one implementation, the two layers of elongated members may be defined by a netting material.
In another embodiment, a first path defining means may be defined by plurality of projections, or dimples, that extend away from a backing surface (e.g., adjacent to a top side of the pad, opposite from the patient contacting side,) in face-to face relation with a fluid retention member within the fluid containing layer. In turn, interconnected, tortuous pathways are defined around the projections and extend to at least one port for fluidly interconnecting the fluid containing layer and the sorption-based device.
In one approach, the apparatus may include a fluid containing layer that includes an enclosure that may be fluid-tight and restrict the passage of vapor and gas therethrough. For example, the enclosure may be of a multilaminate construction including a first vessel that comprises a fluid diffusion barrier material (e.g., a metal foil), and a second vessel comprising a reinforcement material (e.g., a polymer-based material). In one arrangement, two reinforcement layers are utilized, one comprising polyethylene and another comprising polyester.
The sorption-based device may include a sorption-based material for sorping vaporized fluid (e.g., a desiccant), and a second path defining means for defining a second plurality of vaporized fluid diffusion paths between the sorption material and at least one port that fluidly interconnects the sorption-based device fluid containing layer. As may be appreciated, the second path defining means may facilitate diffusion of vaporized fluid across the lateral extent of the sorption material. In this regard, the second plurality of vaporized fluid diffusion paths may have corresponding end locations that are distributed across the lateral extent of the sorption material, thereby facilitating uniform diffusion of vaporized fluid and corresponding sorption thereof.
The second plurality of vaporized diffusion paths may be provided to be tortuous paths. In one embodiment, the second plurality of vaporized fluid diffusion paths may each pass through at least two layers. For example, the first path defining means may comprise a first plurality of elongated members arranged in the first layer and oriented in a first direction, and a second plurality of elongated members arranged in the second layer and orientated in a second direction transverse to said first direction (e.g., to define a cross-hatch pattern). The first plurality of elongated members may be arranged within the first layer in a parallel fashion and the second plurality of elongated members may be arranged in the second layer in a parallel fashion. In one embodiment, the two layers of elongated members may be defined by a netting material.
Additionally, the sorption-based device may comprise at least one spacer member extending through the sorptive material to define at least one corresponding channel for receiving vaporized fluid therethrough, wherein the vaporized fluid may achieve increased contact with the sorption material. More preferably, a plurality of spacer members may be provided to define a corresponding plurality of channels that extend through the sorptive material in spaced relation to each other so as to further provide for enhanced contact between vaporized fluid and sorptive material. In turn, such increased contact yields increased/efficient liquid cooling capabilities, thereby facilitating rapid patient cooling. In one embodiment, a plurality of spacer members are oriented transverse to a second path defining means (e.g., perpendicular), wherein vaporized fluid is distributed across end locations of a plurality of channels for diffusion into and distribution along the plurality of channels.
The sorption-based device also may be provided to include a phase-change material (e.g., a hydrated salt or paraffin-based material) for extracting thermal energy attendant to sorption of vaporized fluid by the sorptive material. In this regard, it is preferable that at least a portion of the phase-change material be located directly adjacent to at least a portion of the sorptive material. By way of example, a plurality of spacer members may be disposed transversely to a second path defining means, with sorptive material located adjacent to each side of each spacer member and a phase-change material disposed therebetween (e.g., to yield a multi-layered, laminar arrangement). In such an arrangement, a fluid diffusion barrier may be disposed between the adjacently located sorptive material and phase-change material. For example, the phase-change material may be disposed within a sealed pouch comprising a metal-based foil.
The adhesive contact surface of the apparatus may be provided to have a peel strength of approximately 10 gm/inch, thereby facilitating the establishment and maintenance of intimate contact for thermal exchange with a patient, while accommodating removal of the pad after use. In one approach, a removable liner may be provided across the adhesive surface and may be readily removable, e.g. for removal immediately prior to use of the apparatus.
In one embodiment, a conformable, thermally-conductive layer may be disposed between an adhesive contact surface and fluid containing layer of the pad. The conformable, thermally-conductive layer may be sufficiently thick and comprised of a sufficiently conformable material so as to conform to the contours of a patient's skin and envelop skin hair. As a result, insulating air pockets between the pad and the skin of a patient may be reduced. The conformable, thermally-conductive layer also provides for efficient thermal exchange therethrough between the skin of a patient and the fluid containing layer. In this regard, the conformable, thermally-conductive layer may advantageously comprise of a material having a coefficient of thermal conductivity of at least about 2 cal/hr-cm-° C.
The conformable, thermally-conductive layer may comprise a first material, such as a liquid (e.g., water), suspended in a matrix defined by a second material, such as a polymer. In this regard, the liquid preferably comprises between about 30 to 95 percent by weight of the total weight of the first and second materials.
The adhesive surface and thermally-conductive layer may be separately comprised of distinct materials. Alternatively, a thermally-conductive layer may be comprised of a hydrogel material having sufficient adhesive properties so as to integrally provide the adhesive surface.
In one implementation, an insulating layer may be disposed on the side of the pad not intended for patient contact (e.g., a top side). The insulating layer inhibits heat transfer between the surrounding air and the fluid containing layer, thereby enhancing the efficiency of the pad. Preferably, the insulating layer is comprised of a material having a coefficient of thermal conductivity of less than about 1.00 cal/hr-cm-° C.
As may be appreciated, the present invention further provides an inventive method for providing a cooled contact surface, e.g., for contact cooling a patient. The method comprises the steps of vaporizing fluid contained in a fluid containing layer of a contact pad having an adhesive surface for patient contact, and sorping the vaporized fluid within a sorption-based device, fluidly interconnectable to the fluid containing layer, wherein a cooled adhesive surface is provided on the contact pad.
The method may include the step of selectively establishing fluid interconnection between the fluid containing layer of the contact pad and the sorption-based device. By way of example, the selectively establishing step may provide for the control of a port, located between the fluid containing layer and the sorption-based device, from a closed position to an open position. In another approach, the establishing step may provide for controlling a degree of fluid interconnection so as to control a rate of cooling, e.g., by controlling the size of an opening defined by the port. In such approaches, a port control member may interface with and be moveable relative to the port to yield the desired control. In one arrangement, port control may be achieved by simply removing a port control member from the port. In one implementation, the port may be biased, e.g., spring loaded, wherein the port moves automatically opens upon relative movement, e.g., removal of a port control member relative to the port.
The method may further include the steps of providing a sorption-based device at an internal pressure less than an internal pressure of the fluid containing layer prior to fluid interconnection therebetween. In one approach, the sorption-based device may be provided at a predetermined subatmospheric pressure. In turn, upon the establishment of fluid interconnection between the sorption-based device and fluid containing layer, the differential pressure automatically facilitates vaporization of fluid within the fluid containing layer of the pad.
The vaporizing step of the method may provide for vaporization of fluid contained in a fluid retention member, located within the fluid containing layer, across the lateral extent of the fluid retention member. That is, by retaining fluid in a fluid retention member, a more uniform vaporization and cooling effect may be realized. In turn, the method may also include a step of diffusing vaporized fluid across the lateral extent of the fluid retention member to at least one port disposed between the fluid containing layer and the sorption-based device. In this regard, such diffusion may be achieved by passing the vaporized fluid through each of a plurality of vapor diffusion paths defined between the fluid retention member and the port(s).
The method may include the step of disposing a sorption material between each of a plurality of spacer members located within the sorption-based device. Correspondingly, the method may provide for diffusion of the vaporized fluid between at least one port, located between the fluid containing layer and the sorption-based device, and ends of the plurality spacer members. In this regard, diffusion of the vaporized fluid may be provided along a plurality of diffusion paths. By way of example, the plurality of diffusion paths may be defined by a path defining means, wherein the plurality of spacer members may be oriented in a transverse manner to the path defining member. In such an arrangement, the path defining means effectively functions to distribute vaporized fluid laterally along the diffusion paths to the ends of each of a plurality of channels defined by the spacer members.
The method may further provide for extracting thermal energy released in conjunction with the sorption of vaporized fluid. In this regard, a phase-change material may be utilized to extract the thermal energy. In one embodiment, a phase-change material may be disposed in adjacent to a sorption material between each pair of a plurality of spacer members within a sorption-based device.
The method may include the step of contacting the adhesive contact surface of the pad to a patient during at least a portion of the vaporizing step and said sorption step, wherein thermal energy is conductively transferred from the patient to said pad across the adhesive contact surface. Further, the contacting step may include the substep of removing a protective liner from the adhesive surface prior to the adhesively engaging step.
The method may further include the step of packaging the pad and sorption-based device together at a first location (e.g., a production facility), and unpackaging such components at a second location (e.g., an emergency patient care site) prior to use. Relatedly, the fluid containing layer of the pad and sorption-based device may be physically preconnected as packaged for ready fluid interconnection upon unpackaging, or may otherwise be adapted for ready physical connection after unpackaging.
Numerous additional aspects and advantages will become apparent to those skilled in the art upon consideration of further description that follows.
As shown, contact pad 10 may comprise a thermally-conductive layer 30 interconnected to fluid containing layer 20 on a bottom-side, or patient contact side thereof. In turn, a removable liner 32 may be connected to an adhesive contact side of the thermally-conductive layer 30, for selective removal prior to use. That is, upon removal of the liner 32, as shown in
The fluid containing layer 20 may include a fluid retention member 22 and a flow path defining member 24 disposed in face-to-face, or laminate, fashion within a sealed enclosure 26. The fluid retention member 22 may comprise of material selected for retaining fluid in a distributed manner across the lateral extent (e.g., lengthwise and widthwise) of the fluid containing layer 20, wherein fluid retained by the fluid retention member 22 may vaporize across the lateral extent of contact pad 10 during use to facilitate efficient and uniform thermal exchange with a patient. Further in this regard, flow path defining member 24 may define a plurality of vaporized fluid diffusion paths between the fluid retention member 22 and port 40, thereby further facilitating efficient and uniform heat transfer during use.
In one approach, the fluid retention member 22 may comprise a woven or non-woven fabric. In the illustrated embodiment, the fluid containing layer 20 may include a vaporizable fluid as initially assembled and sealed. In other embodiments, it is contemplated that the vaporizable fluid may be selectively introduced into the fluid containing layer 20 via an openable/closeable port prior to use. In any case, the vaporizable fluid may comprise water in one approach. In one implementation, the flow path defining member 24 may comprise a netting material.
In one implementation, the sealed enclosure 26 may be fluid-tight and restrict the passage of vapor and gas therethrough. For example, the enclosure may be of a multilaminate construction including a first vessel that comprises a fluid diffusion barrier material (e.g., a metal foil), and a second vessel comprising a reinforcement material (e.g., a polymer-based material). In one arrangement, two reinforcement layers are utilized, one comprising polyethylene and another comprising polyester.
As shown in
In one approach, the enclosure 130 may be fluid-tight and restrict the passage of vapor and gas therethrough. For example, the enclosure may be of a multilaminate construction including a first vessel that comprises a fluid diffusion barrier material (e.g., a metal foil), and a second vessel comprising a reinforcement material (e.g., a polymer-based material). In one arrangement, two reinforcement layers are utilized, one comprising polyethylene and another comprising polyester.
In one embodiment, the spacer members 110 may be defined by a netting material. More particularly, such netting may be an extruded material (e.g., comprising polyethylene or polypropylene) and may be of a woven nature so as to define corresponding channel regions. In turn, each spacer member 110 may define a corresponding channel region having a thickness, or width, of between about 0.5 mm and 2 mm for vaporized liquid refrigerant passage therethrough.
In one embodiment, the sorptive material may comprise a desiccant material. By way of example, the desiccant material may include one or more materials selected from a group consisting of: zeolite, barium oxide, activated alumina, silica gel, glycerine, magnesium perchlorate, calcium sulfate, calcium oxide, activated carbon, calcium chloride, glycerine silica gel, alumina gel, calcium hydride, phosphoric anhydride, phosphoric acid, potassium hydroxide and sodium sulfate.
An exemplary desiccant is a surface modified porous material. The porous material can be a material such as activated carbon or silica. The surface modification can include impregnating the porous material with one or more metal salts such as a metal salt selected from the group consisting of calcium chloride, lithium chloride, lithium bromide, magnesium chloride, calcium nitrate, potassium fluoride and the like. The porous support material is preferably loaded with from about 20 to about 80 weight percent of the metal salt and more preferably from about 40 to about 60 weight percent of the metal salt.
By way of example, the phase-change material may comprise a hydrated salt and/or a paraffin material. The phase-change material may have a transition temperature of from about 10° C. to about 80° C. More preferably, the phase-change material may have a transition temperature of at least about 25° C. It may be desirable to utilize phase-change materials that have a transition temperature above ambient (e.g., 25° C.) to simplify the storage of such materials. As used herein, transition temperature refers to the temperature at which the phase-change material undergoes a phase-change, e.g., from a solid to a liquid.
The phase-change material may also be provided to have a high energy density. The energy density may be measured in terms of mass (mass energy density) or volume (volumetric energy density). Mass energy density refers to the amount of energy that is released or adsorbed by the phase-change material per unit mass of the phase-change material. Volumetric energy density refers to the amount of energy that is released or adsorbed by phase-change material per unit volume of the phase-change material. Preferably, the phase-change material may have a volumetric energy density of at least about 200 J/cm3, more preferably at least about 275 J/cm3 and most preferably at least about 350 J/cm3. Preferred phase-change materials include inorganic compounds such as disodium sulfate decahydrate, disodium hypophosphate dodecahydrate, barium hydroxide octahydrate, paraffins such as octadecane, and combinations thereof. In order to provide a range of transition temperature, it may be desirable to mix two or more phase-change materials.
In some embodiments, it may be desirable to restrict mixing of the desiccant and the phase-change material, especially at or above the transition temperature of the phase-change material. When the phase-change material is in a liquid or gas phase, as is the case above its transition temperature, it may cause unwanted chemical reactions with the desiccant or lessen thermal communication with the desiccant by reducing the amount of phase-change material in contact with the desiccant. In such a case, a fluid diffusion barrier may be employed to prevent the phase-change material from contacting the desiccant or from changing its shape. For example, the phase-change material may be disposed within a pouch that acts as a fluid diffusion barrier.
The fluid diffusion barrier can be any type of barrier which prevents the phase-change material from interspersing with the desiccant. Preferably, the fluid diffusion barrier also has a high thermal conductivity to enable efficient thermal communication between the desiccant and phase-change material. Preferred fluid diffusion barriers include simple plastic films such as polyethylene, nylon, PVC, metal foils with plastic heat seal layers such as those sold by Toyo Aluminum (Osaka, Japan), metallized plastic barriers such as those sold by DuPont (Wilmington, Del.) and Rexam (London, England), multilayer plastic layers and combinations thereof. In addition to preventing fluid diffusion, the phase-change material may be disposed within the fluid diffusion barrier to provide mechanical protection so that it retains its original shape and is resistant to physical or chemical changes in its structure. This may be accomplished by any means known in the art, including heat sealing.
Referring again now to
In this regard, reference is now made to
In this regard, it may be appreciated that the cooling apparatus 1 yields a convenient and easy to use solution for patient cooling. In particular, the cooling apparatus 1 may be packaged as a unit at a production location and shipped to an emergency patient care site for storage until needed. When needed for patient cooling, the cooling apparatus 1 may be removed from the packaging and positioned relative to a patient. In particular, the liner 32 may be readily removed from the adhesive contact surface 34. In turn, the adhesive contact surface may be positioned relative to and placed onto a patient, wherein an adhesive interface may be realized between the pad 10 of the cooling apparatus 1 and the patient. To initiate cooling, the port control member 42 may be simply removed from port 40, wherein the spring member 44 automatically opens the port 40 to establish a fluid interconnection between the contact pad 10 and sorption-based device 100. Pursuant thereto, the fluid in the fluid containing layer 20 of contact pad 10 may vaporize and concomitantly yield a cooling effect at the contact surface 34 so as to conductively absorb heat from the patient. In conjunction with fluid vaporization, the vaporized fluid may be sorped within the sorption-based device 100. In this regard, the cooling process may continue, free from the use of external power services, for an extended time, e.g., between about 15 minutes to several hours during which a patient may be transported by an emergency vehicle to a hospital or other primary patient care site.
The above-noted embodiments are for the purpose of illustration and are not intended to limit the scope of the present invention or patent. Rather, various modifications, adaptations and extensions of the invention will be apparent to those skilled in the art and are intended to be within the scope of the present invention.
| Patent | Priority | Assignee | Title |
| 11865034, | Jan 27 2015 | Medivance Incorporated | Medical pad and system for thermotherapy |
| Patent | Priority | Assignee | Title |
| 2250325, | |||
| 2726658, | |||
| 3091242, | |||
| 3212286, | |||
| 3429315, | |||
| 3734293, | |||
| 3867939, | |||
| 3927671, | |||
| 3995621, | Jan 27 1976 | Liquid cooled brassiere and method of diagnosing malignant tumors therewith | |
| 4108146, | May 16 1977 | Bendable thermal pack unit | |
| 4114620, | Mar 02 1977 | Moore-Perk Corporation | Patient treatment pad for hot or cold use |
| 4118946, | Nov 23 1976 | Personnel cooler | |
| 4149541, | Oct 06 1977 | Gaymar Industries, Inc | Fluid circulating pad |
| 4154245, | Jul 11 1977 | PAT O DAILY, AS TRUSTEE UNDER THE PAT O DAILY REVOCABLE TRUST, DATED OCTOBER 27, 1989 | Apparatus for local hypothermia |
| 4161210, | Jan 10 1975 | Temperature increase system | |
| 4195631, | Jun 14 1978 | Flow regulating device useable in plasma pheresis | |
| 4444727, | Dec 18 1979 | Matsushita Electric Industrial Co. Ltd. | Hydrogen gas purification apparatus |
| 4508123, | Jun 01 1983 | Edwards Lifesciences Corporation | Thermodilution injectate assembly |
| 4580408, | Mar 12 1984 | Water vest for motocross riders | |
| 4834705, | May 11 1987 | BEECH MEDICAL PRODUCTS, INC | Drug dispensing system |
| 4919134, | Jul 31 1987 | Becton, Dickinson and Company | Thermoelectric chiller and automatic syringe |
| 4962761, | Feb 24 1987 | Thermal bandage | |
| 5000252, | Feb 22 1990 | Wright State University | Thermal energy storage system |
| 5062414, | Feb 08 1989 | OSSUR HF | Simplified orthopaedic back support |
| 5097829, | Mar 19 1990 | THERMOTEK, INC | Temperature controlled cooling system |
| 5111668, | Oct 05 1990 | Mainstream Engineering Corp. | Cooling device and method for hazardous materials suits |
| 5113666, | Oct 05 1990 | MAINSTREAM ENGINEERING CORP | Cooling device for hazardous materials suits |
| 5133348, | Mar 16 1990 | Contoured cooling pack | |
| 5190032, | Mar 15 1990 | Federal Leasing Rehab Company | Apparatus for controlling the temperature of an area of the body |
| 5261241, | Feb 08 1991 | Japan Pionics Co., Ltd. | Refrigerant |
| 5268022, | Mar 07 1991 | BOC GROUP PLC, THE | Gas separation method and apparatus |
| 5289695, | Oct 05 1990 | Mainstream Engineering Corp. | Adsorption cooling device and method for hazardous materials suits |
| 5304213, | Jun 14 1993 | Gentherm Medical, LLC | Hyper-hypothermia blanket with filtration properties |
| 5383919, | May 18 1993 | OTTO BOCK HEALTHCARE CANADA, LTD ; QAL MEDICAL, LLC | Thermal therapy pad |
| 5411541, | Aug 05 1993 | Oansh Designs Ltd. | Portable fluid therapy device |
| 5423751, | Feb 18 1993 | Contrast media dispensing apparatus | |
| 5466250, | Jan 23 1991 | Aircast LLC; AI ASSET ACQUISITION COMPANY LLC | Automatic fluid compress and circulating system |
| 5470353, | Oct 20 1993 | UNITED STATES MANUFACTURING COMPANY, LLC | Post-operative thermal blanket |
| 5486207, | Sep 20 1994 | Thermal pad for portable body heating/cooling system and method of use | |
| 5514169, | Dec 19 1994 | Tyco Healthcare Group LP | Warming blanket having multiple inlets |
| 5545194, | Sep 30 1994 | 3M Innovative Properties Company | Convertible thermal blanket |
| 5609620, | Jun 06 1995 | Pat O., Daily; DAILY, PAT O , AS TRUSTEE UNDER THE PAT O DAILY REVOCABLE TRUS 10-27-89 | Cardiac cooling jacket |
| 5624477, | May 09 1991 | BOC GROUP PLC, THE | Pressure swing adsorption plants |
| 5658325, | May 18 1993 | General Electric Capital Corporation; ARIZANT HEALTHCARE INC | Convective thermal blanket |
| 5662695, | Sep 05 1990 | Breg, Inc.; BREG, INC | Occlusion-resistant fluid pad conformable to a body for therapeutic treatment thereof |
| 5683439, | Oct 20 1993 | UNITED STATES MANUFACTURING COMPANY, LLC | Post-operative thermal blanket |
| 5733318, | Sep 30 1994 | 3M Innovative Properties Company | Convertible thermal blanket |
| 5806335, | Feb 13 1997 | Pabban Development Inc | Cold therapy device |
| 5887437, | Sep 30 1997 | BEEKLEY CORPORATION | Self-adhering cold pack |
| 5913849, | Mar 27 1992 | Coloplast A/S | Heat dressing |
| 6019783, | Mar 02 1999 | ZOLL CIRCULATION, INC | Cooling system for therapeutic catheter |
| 6047106, | Jan 30 1997 | Water heating unit with integral thermal energy storage | |
| 6083418, | Jun 02 1998 | Modine Manufacturing Company | Density stabilized phase change material |
| 6117164, | Jun 06 1997 | DJO, LLC | Flexible multijoint therapeutic pads |
| 6197045, | Jan 04 1999 | Medivance Incorporated | Cooling/heating pad and system |
| 6238427, | Mar 30 1999 | Therapeutic heat transfer pads | |
| 6257011, | Sep 16 1999 | U T Battelle LLC | Personal cooling apparatus and method |
| 6319599, | Jul 14 1992 | Phase change thermal control materials, method and apparatus | |
| 6349560, | May 19 1999 | COOL-SYSTEM BEV GMBH | Apparatus and method for the cooling of a liquid in a container |
| 6354099, | Apr 11 2000 | General Electric Capital Corporation; ARIZANT HEALTHCARE INC | Cooling devices with high-efficiency cooling features |
| 6364937, | May 10 2000 | Humidity control system | |
| 6375674, | Jan 04 1999 | Medivance, Inc. | Cooling/heating pad and system |
| 6389839, | May 07 2001 | TEMPRA TECHNOLOGY INC | Cooling and dispensing of products |
| 6436130, | Mar 02 1999 | ZOLL CIRCULATION, INC | Cooling system for therapeutic catheter |
| 6454792, | Dec 24 1998 | ZOLL CIRCULATION, INC | Cooling system for indwelling heat exchange catheter |
| 6463212, | Jan 30 1997 | Water heating unit with integral thermal energy storage | |
| 6503297, | Feb 07 2001 | The BOC Group, Inc. | Adsorption processes |
| 6508859, | Nov 13 2000 | Pentair Filtration Solutions, LLC | Method and apparatus for removing air or gas from fluid |
| 6559096, | Oct 18 2000 | NANOPORE, INC | Desiccant composition |
| 6584797, | Jun 06 2001 | PELICAN NANOCOOL HOLDINGS, LLC | Temperature-controlled shipping container and method for using same |
| 6591630, | Aug 17 2001 | NANOPORE, INC | Cooling device |
| 6601404, | Aug 17 2001 | NANOPORE INC | Cooling device |
| 6620187, | Jan 04 1999 | Medivance Incorporated | Patient temperature control system with make-up fluid supply |
| 6645232, | Jan 04 1999 | Medivance Incorporated | Patient temperature control system with fluid pressure maintenance |
| 6669715, | Feb 27 2002 | Medivance Incorporated | Medical thermal energy exchange pad |
| 6688132, | Jun 06 2001 | PELICAN NANOCOOL HOLDINGS, LLC | Cooling device and temperature-controlled shipping container using same |
| 6692518, | Feb 27 2002 | Medivance Incorporated | Patient temperature control system |
| 6701724, | Jun 06 2001 | PELICAN NANOCOOL HOLDINGS, LLC | Sorption cooling devices |
| 6755801, | Dec 01 1998 | HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT | Dialysis pressure monitoring with clot suppression |
| 6802885, | Jan 25 2002 | Hoeganaes Corporation | Powder metallurgy lubricant compositions and methods for using the same |
| 6818012, | Oct 11 2001 | Medivance, Incorporated | Patient temperature control system with fluid temperature response |
| 6858068, | Sep 30 2002 | Nanopore, Inc.; NANOPORE, INC | Device for providing microclimate control |
| 6878156, | Jul 26 2002 | ZOLL CIRCULATION, INC | Portable cooler for heat exchange catheter |
| 6960243, | Jul 23 2002 | Nanopore, Inc. | Production of drinking water from air |
| 6968711, | Jun 06 2001 | PELICAN NANOCOOL HOLDINGS, LLC | Temperature controlled shipping containers |
| 7022099, | Mar 17 2003 | ARG MEDICAL SOLUTIONS LLC | Extracorporeal blood handling system with automatic flow control and methods of use |
| 7063718, | Jan 23 1998 | ZOLL CIRCULATION, INC | Selective organ hypothermia method and apparatus |
| 7097657, | Feb 18 2003 | ZOLL CIRCULATION, INC | Dual IV bag arrangement for intravascular temperature control catheter cooling circuit |
| 7172586, | Aug 24 2001 | ZOLL CIRCULATION, INC | Method of inotropic treatment of circulatory failure using hypothermia |
| 7827815, | Apr 18 2006 | Medivance, Inc.; Medivance Incorporated | Apparatus and method for cooling liquid in intravascular cooling system |
| 8047010, | Apr 18 2006 | Medivance Incorporated | Apparatus and method for cooling liquid in intravascular cooling system |
| 20030150232, | |||
| 20060030916, | |||
| 20060074469, | |||
| 20060124141, | |||
| 20060136023, | |||
| 20060161232, | |||
| 20060247744, | |||
| 20060287697, | |||
| 20070043409, | |||
| 20080255644, | |||
| 20090099629, | |||
| 20090131835, | |||
| WO1999044552, | |||
| WO2003086253, |
| Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
| Jun 10 2008 | CARSON, GARY A | Medivance Incorporated | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 041753 | /0496 | |
| May 10 2016 | Medivance Incorporated | (assignment on the face of the patent) | / |
| Date | Maintenance Fee Events |
| Sep 20 2022 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
| Date | Maintenance Schedule |
| Apr 16 2022 | 4 years fee payment window open |
| Oct 16 2022 | 6 months grace period start (w surcharge) |
| Apr 16 2023 | patent expiry (for year 4) |
| Apr 16 2025 | 2 years to revive unintentionally abandoned end. (for year 4) |
| Apr 16 2026 | 8 years fee payment window open |
| Oct 16 2026 | 6 months grace period start (w surcharge) |
| Apr 16 2027 | patent expiry (for year 8) |
| Apr 16 2029 | 2 years to revive unintentionally abandoned end. (for year 8) |
| Apr 16 2030 | 12 years fee payment window open |
| Oct 16 2030 | 6 months grace period start (w surcharge) |
| Apr 16 2031 | patent expiry (for year 12) |
| Apr 16 2033 | 2 years to revive unintentionally abandoned end. (for year 12) |